Assembly Biosciences Inc (ASMB) — Cash Flow Reinvestment Rate
Assembly Biosciences Inc (ASMB) has a Cash Flow Reinvestment Rate of 1.49x as of December 2025, reinvesting $21.27 Million (capex $24.00K plus investments $21.25 Million) from operating cash flow of $14.24 Million. Check Assembly Biosciences Inc (ASMB) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Assembly Biosciences Inc Cash Flow Reinvestment Rate (2017–2023)
Historical reinvestment intensity for Assembly Biosciences Inc across 2 annual periods. Explore ASMB long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Assembly Biosciences Inc (2017–2023)
Year-by-year capital reinvestment analysis for Assembly Biosciences Inc. For live market cap and broader valuation context, see Assembly Biosciences Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.64x | $37.33 Million | $22.74 Million | $255.00K | ▼ -80.5% |
| 2017 | 8.41x | $15.64 Million | $1.86 Million | $864.56K | — |